GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹3,606 Cr | ₹3,410 Cr | ₹2,798 Cr | ₹2,494 Cr | ₹3,708 Cr |
What is the latest Total Current Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Current Assets |
|---|---|
| Mar2026 | ₹3,606 Cr |
| Mar2025 | ₹3,410 Cr |
| Mar2024 | ₹2,798 Cr |
| Mar2023 | ₹2,494 Cr |
| Mar2022 | ₹3,708 Cr |
How is Total Current Assets of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,606 Cr | 5.76 | |
| Mar2025 | ₹3,410 Cr | 21.85 | |
| Mar2024 | ₹2,798 Cr | 12.19 | |
| Mar2023 | ₹2,494 Cr | -32.73 | |
| Mar2022 | ₹3,708 Cr | - | |
Compare Total Current Assets of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹41,257.4 Cr | 1.5% | 12% | -25.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 1.5% |
12% |
-25.9% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses